Document:

<PAGE>   1

                                                                   EXHIBIT 10.11

                                  SEMINIS, INC.
                         SEMINIS VEGETABLE SEEDS, INC.
      EXTENSION AND AMENDMENT OF MODIFICATION AND INTERIM WAIVER AGREEMENT

To the Lender Parties to the Credit
    Agreement Identified Below

Ladies and Gentlemen:

        We refer to the Modification and Interim Waiver Agreement dated as of
December 29, 2000 (the "Modification Agreement") among the undersigned, SEMINIS,
INC., an Illinois corporation ("Seminis"), SEMINIS VEGETABLE SEEDS, INC., a
California corporation ("SVS" ) and SVS HOLLAND B.V., a private company with
limited liability incorporated under the laws of The Netherlands ("SVS Holland"
and, together with Seminis and SVS, individually a "Borrower" and collectively
the "Borrowers"), the Banks from time to time party thereto and Harris Trust and
Savings Bank, as administrative agent for the Banks (the "Administrative
Agent"), as heretofore or hereafter amended, capitalized terms used without
definition below to have the meanings ascribed to them in the Modification
Agreement.

        Pursuant to the Modification Agreement the Required Banks waived
compliance by the Borrowers with Sections 7.20 and 7.22 of the Credit Agreement
for the period ending on the Expiry Date. The Borrowers have requested that the
Required Banks extend the Expiry Date (and therefore the Waiver Period) from
April 30, 2001 to May 22, 2001, that the Banks extend the date on which the
Borrowers are required to pay the second installment of the principal payment on
the Term Loans that was originally payable on December 31, 2000, from April 30,
2001 to May 22, 2002, and that the Banks extend the date on which the Borrowers
are required to pay the first installment of Additional Margin pursuant to
Section 14 of the Modification Agreement from April 30, 2001 to May 22, 2001,
and the Banks are willing to do so on the terms and conditions contained herein.
Accordingly, upon satisfaction of the conditions precedent to effectiveness set
forth below, the Borrowers and the Banks agree as follows:

        1. Extension of Interim Waivers with Respect to Certain Financial
Covenants. Section 1 of the Modification Agreement shall be amended by replacing
the date "April 30, 2001" appearing therein with the date "May 22, 2001".

        2. Extension of Time for Principal Payment. The first sentence of
Section 2 of the Modification Agreement shall be amended by replacing the date
"April 30, 2001" appearing therein with the date "May 22, 2001".

        3. Extension of Additional Interest Payment Date.. Section 14 of the
Modification Agreement is hereby amended by replacing the date "April 30, 2001"
everywhere it appears therein with the date "May 22, 2001".

<PAGE>   2

        4. Representations and Releases. Each Borrower hereby represents,
warrants, acknowledges and agrees that (i) there are no set offs, counterclaims
or defenses against the Notes, the Credit Agreement (as amended or otherwise
modified hereby) or any other Loan Documents (as amended or otherwise modified
hereby or by the security agreement amendments) and (ii) there are no claims
(absolute or contingent or matured or unmatured) or causes of action by any
Borrower against any Bank or any Agent in connection with the Credit Agreement,
the Notes and the other Loan Documents. Notwithstanding the immediately
preceding sentence and as further consideration for the agreements and
understandings contained herein, each Borrower hereby releases the Agents and
the Banks, their respective predecessors, officers, directors, employees,
agents, attorneys, affiliates, subsidiaries, successors and assigns, from any
liability, claim, right or cause of action which now exists or hereafter arises
as a result of acts, omissions or events occurring on or prior to the date
hereof, whether known or unknown, in connection with the Credit Agreement, the
Notes and the other Loan Documents.

        5. Miscellaneous. Except as specifically modified hereby, all of the
terms, conditions and provisions of the Credit Agreement shall stand and remain
unchanged and in full force and effect. The Borrowers' obligations under Section
12.8 of the Credit Agreement shall be unaffected by the waiver contained herein.
No reference to this Extension and Amendment of Modification and Interim Waiver
Agreement (the "Extension") need be made in any instrument or document at any
time referring to the Modification Agreement, a reference to the Modification
Agreement in any of such to be deemed to be a reference to the same as modified
hereby. This Extension may be executed in counterparts and by separate parties
hereto on separate counterparts, each to constitute an original but all of which
shall constitute one and the same instrument. The Borrowers hereby confirm that
all representations and warranties made by them in the Loan Documents (as
defined in the Credit Agreement) are true and correct as of the date hereof
except to the extent that any of same expressly relate to any earlier date and
acknowledge that their obligations under the Loan Documents are justly and truly
owing without defense, offset or counterclaim. The waivers provided for herein
shall be strictly construed and limited as hereinafter provided. This Extension
shall become effective upon receipt by the Administrative Agent of counterparts
hereof which, taken together, bear the signatures of the Borrowers and the
Banks. This Extension shall be deemed to be a "Loan Document" for purposes of
the Credit Agreement and the other Loan Documents. This Extension shall be
construed in accordance with and governed by the laws of the state of Illinois.

                                      -2-
<PAGE>   3

      Dated and effective as of April 30, 2001.

                                     SEMINIS, INC.

                                     By

                                       Its______________________________________

                                     SEMINIS VEGETABLE SEEDS, INC.

                                     By

                                       Its______________________________________

                                     SVS HOLLAND B.V.

                                     By

                                       Its______________________________________

                                     HARRIS TRUST AND SAVINGS BANK,
                                       individually and as Administrative Agent

                                     By
                                       Its Vice President

                                     CREDIT AGRICOLE INDOSUEZ

                                     By

                                       Its______________________________________

                                     BANK OF AMERICA, N.A.

                                     By

                                       Its______________________________________

                                      -3-
<PAGE>   4

                                     THE BANK OF NOVA SCOTIA

                                     By

                                       Its______________________________________

                                     COMERICA BANK

                                     By

                                       Its______________________________________

                                     BANK ONE

                                     By

                                       Its______________________________________

                                     BNP PARIBAS

                                     By

                                       Its______________________________________

                                     By

                                       Its______________________________________

                                       -4-
<PAGE>   5

                                     UNION BANK OF CALIFORNIA, N.A.

                                     By

                                       Its______________________________________

                                     FLEET NATIONAL BANK

                                     By

                                       Its______________________________________

                                     FORTIS CAPITAL CORP.

                                     By

                                       Its______________________________________

                                     COOPERATIEVE CENTRALE RAIFFEISEN-
                                       BOERENLEENBANK B.A., "RABOBANK
                                       NEDERLAND", NEW YORK BRANCH

                                     By

                                       Its______________________________________

                                     SANWA BANK CALIFORNIA

                                     By

                                       Its______________________________________

                                     THE FUJI BANK, LIMITED

                                     By

                                       Its______________________________________

                                      -5-
<PAGE>   6

                                     THE MITSUBISHI TRUST AND BANKING
                                       CORPORATION

                                     By

                                        Its_____________________________________

                                     US BANCORP AG CREDIT, INC.

                                     By

                                        Its_____________________________________

                                     THE DAI-ICHI KANGYO BANK, LTD.

                                     By

                                       Its______________________________________

                                      -6-<PAGE>   1

                                                                   EXHIBIT 10.03

                              OCULAR SCIENCES, INC.

                              AMENDED AND RESTATED
                        1997 DIRECTORS STOCK OPTION PLAN

        As adopted June 2, 1997, as amended July 14, 1997 and as amended
                         and restated November 28, 2000

        1. PURPOSE. This Amended and Restated 1997 Directors Stock Option Plan
(this "Plan") is established to provide equity incentives for nonemployee
members of the Board of Directors of Ocular Sciences, Inc. (the "COMPANY"), who
are described in Section 6.1 below, by granting such persons options to purchase
shares of stock of the Company.

        2. ADOPTION AND STOCKHOLDER APPROVAL. After this Plan is adopted by the
Board of Directors of the Company (the "BOARD"), this Plan will become effective
on the time and date (the "EFFECTIVE DATE") on which the registration statement
filed by the Company with the Securities and Exchange Commission ("SEC") under
the Securities Act of 1933, as amended (the "SECURITIES ACT"), to register the
initial public offering of the Company's Common Stock is declared effective by
the SEC. This Plan shall be approved by the stockholders of the Company,
consistent with applicable laws, within twelve (12) months after the date this
Plan is adopted by the Board.

        3. TYPES OF OPTIONS AND SHARES. Options granted under this Plan shall be
non-qualified stock options ("NQSOS"). The shares of stock that may be purchased
upon exercise of Options granted under this Plan (the "SHARES") are shares of
the Common Stock of the Company.

        4. NUMBER OF SHARES. The maximum number of Shares that may be issued
pursuant to Options granted under this Plan (the "MAXIMUM NUMBER") is 400,000
Shares, subject to adjustment as provided in this Plan. If any Option is
terminated for any reason without being exercised in whole or in part, the
Shares thereby released from such Option shall be available for purchase under
other Options subsequently granted under this Plan. At all times during the term
of this Plan, the Company shall reserve and keep available such number of Shares
as shall be required to satisfy the requirements of outstanding Options granted
under this Plan; provided, however that if the aggregate number of Shares
subject to outstanding Options granted under this Plan plus the aggregate number
of Shares previously issued by the Company pursuant to the exercise of Options
granted under this Plan equals or exceeds the Maximum Number, then
notwithstanding anything herein to the contrary, no further Options may be
granted under this Plan until the Maximum Number is increased or the aggregate
number of Shares subject to outstanding Options granted under this Plan plus the
aggregate number of Shares previously issued by the Company pursuant to the
exercise of Options granted under this Plan is less than the Maximum Number.

        5. ADMINISTRATION. This Plan shall be administered by the Board or by a
committee of not less than two members of the Board appointed to administer this
Plan (the "COMMITTEE"). As used in this Plan, references to the Committee shall
mean either such Committee or the Board if no Committee has been established.
The interpretation by the Committee of any of the provisions of this Plan or any
Option granted under this Plan shall be final and binding upon the Company and
all persons having an interest in any Option or any Shares purchased pursuant to
an Option.

        6. ELIGIBILITY AND AWARD FORMULA.

             6.1 Eligibility. Options shall be granted only to directors of the
Company who are not employees of the Company or any Parent, Subsidiary or
Affiliate of the Company, as those terms are defined in Section 17 below (each
such person referred to as an "OPTIONEE").

             6.2 Initial Grant. Each Optionee who on or after the Effective Date
is or becomes a member of the Board will automatically be granted an Option for
30,000 Shares (an "INITIAL GRANT") on the later of the Effective Date and the
date such Optionee first becomes a member of the Board.

<PAGE>   2

             6.3 Succeeding Grants. On each annual anniversary of an Optionee's
Initial Grant, provided the Optionee is a member of the Board on such
anniversary date and has served continuously as a member of the Board since the
date of the Optionee's Initial Grant, the Optionee will automatically be granted
an Option for 15,000 Shares (a "SUCCEEDING GRANT").

        7. TERMS AND CONDITIONS OF OPTIONS. Subject to the following and to
Section 6 above:

             7.1 Form of Option Grant. Each Option granted under this Plan shall
be evidenced by a written Stock Option Grant ("GRANT") in such form (which need
not be the same for each Optionee) as the Committee shall from time to time
approve, which Grant shall comply with and be subject to the terms and
conditions of this Plan.

             7.2 Vesting. Options granted under this Plan shall be exercisable
as they vest. The date an Optionee receives an Initial Grant or a Succeeding
Grant is referred to in this Plan as the "START DATE" for such Option.

                  (a) Initial Grants. Each Initial Grant will vest as to two and
seventy-eight one-hundredths percent (2.78%) of the Shares on the last day of
each month following the Start Date, so long as the Optionee continuously
remains a director or consultant of the Company.

                  (b) Succeeding Grants. Each Succeeding Grant will vest as to
two and seventy-eight one-hundredths percent (2.78%) of the Shares on the last
day of each month following the Start Date, so long as the Optionee continuously
remains a director or consultant of the Company.

             7.3 Exercise Price. The exercise price of an Option shall be the
Fair Market Value (as defined in Section 17.4) of the Shares, at the time that
the Option is granted.

             7.4 Termination of Option. Except as provided below in this
Section, each Option shall expire ten (10) years after its Start Date (the
"EXPIRATION DATE"). The Option shall cease to vest when the Optionee ceases to
be a member of the Board or a consultant of the Company. The date on which the
Optionee ceases to be a member of the Board or a consultant of the Company shall
be referred to as the "TERMINATION DATE." An Option may be exercised after the
Termination Date only as set forth below:

                  (a) Termination Generally. If the Optionee ceases to be a
member of the Board or consultant of the Company for any reason except death of
the Optionee or disability of the Optionee (whether temporary or permanent,
partial or total, as determined by the Committee), then each Option then held by
such Optionee, to the extent (and only to the extent) that it would have been
exercisable by the Optionee on the Termination Date, may be exercised by the
Optionee no later than seven (7) months after the Termination Date, but in no
event later than the Expiration Date.

                  (b) Death or Disability. If the Optionee ceases to be a member
of the Board or consultant of the Company because of the death of the Optionee
or the disability of the Optionee (whether temporary or permanent, partial or
total, as determined by the Committee), then each Option then held by such
Optionee, to the extent (and only to the extent) that it would have been
exercisable by the Optionee on the Termination Date, may be exercised by the
Optionee (or the Optionee's legal representative) no later than twelve (12)
months after the Termination Date, but in no event later than the Expiration
Date.

        8. EXERCISE OF OPTIONS.

             8.1 Exercise Period. Subject to the provisions of Section 8.5
below, Options shall be exercisable as they vest.

             8.2 Notice. Options may be exercised only by delivery to the
Company of an exercise agreement in a form approved by the Committee stating the
number of Shares being purchased, the restrictions imposed on the Shares and
such representations and agreements regarding the Optionee's investment intent
and access to information as may be required by the Company to comply with
applicable securities laws, together with payment in full of the exercise price
for the number of Shares being purchased.

             8.3 Payment. Payment for the Shares purchased upon exercise of an
Option may be made (a) in cash or by check; (b) by surrender of shares of Common
Stock of the Company that have been owned by the Optionee for more than six (6)

<PAGE>   3

months (and which have been paid for within the meaning of SEC Rule 144 and, if
such shares were purchased from the Company by use of a promissory note, such
note has been fully paid with respect to such shares) or were obtained by the
Optionee in the open public market, having a Fair Market Value equal to the
exercise price of the Option; (c) by waiver of compensation due or accrued to
the Optionee for services rendered; (d) provided that a public market for the
Company's stock exists, through a "same day sale" commitment from the Optionee
and a broker-dealer that is a member of the National Association of Securities
Dealers (an "NASD DEALER") whereby the Optionee irrevocably elects to exercise
the Option and to sell a portion of the Shares so purchased to pay for the
exercise price and whereby the NASD Dealer irrevocably commits upon receipt of
such Shares to forward the exercise price directly to the Company; (e) provided
that a public market for the Company's stock exists, through a "margin"
commitment from the Optionee and an NASD Dealer whereby the Optionee irrevocably
elects to exercise the Option and to pledge the Shares so purchased to the NASD
Dealer in a margin account as security for a loan from the NASD Dealer in the
amount of the exercise price, and whereby the NASD Dealer irrevocably commits
upon receipt of such Shares to forward the exercise price directly to the
Company; or (f) by any combination of the foregoing.

             8.4 Withholding Taxes. Prior to issuance of the Shares upon
exercise of an Option, the Optionee shall pay or make adequate provision for any
federal or state withholding obligations of the Company, if applicable.

             8.5 Limitations on Exercise. Notwithstanding the exercise periods
set forth in the Grant, exercise of an Option shall always be subject to the
following limitations:

                  (a) An Option shall not be exercisable unless such exercise is
in compliance with the Securities Act and all applicable state securities laws,
as they are in effect on the date of exercise.

                  (b) The Committee may specify a reasonable minimum number of
Shares that may be purchased upon any exercise of an Option, provided that such
minimum number will not prevent the Optionee from exercising the full number of
Shares as to which the Option is then exercisable.

        9. NONTRANSFERABILITY OF OPTIONS. During the lifetime of the Optionee,
an Option shall be exercisable only by the Optionee or by the Optionee's
guardian or legal representative, unless otherwise determined by the Committee.
No Option may be sold, pledged, assigned, hypothecated, transferred or disposed
of in any manner other than by will or by the laws of descent and distribution,
unless otherwise determined by the Committee.

        10. PRIVILEGES OF STOCK OWNERSHIP. No Optionee shall have any of the
rights of a stockholder with respect to any Shares subject to an Option until
the Option has been validly exercised. No adjustment shall be made for dividends
or distributions or other rights for which the record date is prior to the date
of exercise, except as provided in this Plan. The Company shall provide to each
Optionee a copy of the annual financial statements of the Company at such time
after the close of each fiscal year of the Company as they are released by the
Company to its stockholders.

        11. ADJUSTMENT OF OPTION SHARES. In the event that the number of
outstanding shares of Common Stock of the Company is changed by a stock
dividend, stock split, reverse stock split, combination, reclassification or
similar change in the capital structure of the Company without consideration,
the number of Shares available under this Plan and the number of Shares subject
to outstanding Options and the exercise price per share of such outstanding
Options shall be proportionately adjusted, subject to any required action by the
Board or stockholders of the Company and compliance with applicable securities
laws; provided, however, that no fractional shares shall be issued upon exercise
of any Option and any resulting fractions of a Share shall be rounded up to the
nearest whole Share.

        12. NO OBLIGATION TO CONTINUE AS DIRECTOR. Nothing in this Plan or any
Option granted under this Plan shall confer on any Optionee any right to
continue as a director of the Company.

        13. COMPLIANCE WITH LAWS. The grant of Options and the issuance of
Shares upon exercise of any Options shall be subject to and conditioned upon
compliance with all applicable requirements of law, including without limitation
compliance with the Securities Act, compliance with all other applicable state
securities laws and compliance with the requirements of any stock exchange or
national market system on which the Shares may be listed. The Company shall be
under no obligation to register the Shares with the SEC or to effect compliance
with the registration or qualification requirement of any state securities laws,
stock exchange or national market system.

<PAGE>   4

        14. ACCELERATION OF OPTIONS ON CERTAIN CORPORATE TRANSACTIONS. In the
event of (a) a dissolution or liquidation of the Company, (b) a merger or
consolidation in which the Company is not the surviving corporation (other than
a merger or consolidation with a wholly-owned subsidiary, a reincorporation of
the Company in a different jurisdiction, or other transaction in which there is
no substantial change in the stockholders of the Company or their relative stock
holdings and the Options granted under this Plan are assumed, converted or
replaced by the successor corporation, which assumption, conversion or
replacement will be binding on all Optionees), (c) a merger in which the Company
is the surviving corporation but after which the stockholders of the Company
(other than any stockholder which merges (or which owns or controls another
corporation which merges) with the Company in such merger) cease to own their
shares or other equity interests in the Company, (d) the sale of substantially
all of the assets of the Company, or (e) the acquisition, sale or transfer of
more than 50% of the outstanding shares of the Company by tender offer or
similar transaction, the vesting of all options granted pursuant to this Plan
will accelerate and the options will become exercisable in full prior to the
consummation of such event at such times and on such conditions as the Committee
determines, and if such options are not exercised prior to the consummation of
the corporate transaction, they shall terminate in accordance with the
provisions of this Plan.

        15. AMENDMENT OR TERMINATION OF PLAN. The Board may at any time
terminate or amend this Plan or any outstanding option, provided that the Board
may not terminate or amend the terms of any outstanding option without the
consent of the Optionee. In any case, no amendment of this Plan may adversely
affect any then outstanding Options or any unexercised portions thereof without
the written consent of the Optionee.

        16. TERM OF PLAN. Options may be granted pursuant to this Plan from time
to time within a period of ten (10) years from the Effective Date.

        17. CERTAIN DEFINITIONS. As used in this Plan, the following terms shall
have the following meanings:

             17.1 "PARENT" means any corporation (other than the Company) in an
unbroken chain of corporations ending with the Company if each of such
corporations other than the Company owns stock possessing 50% or more of the
total combined voting power of all classes of stock in one of the other
corporations in such chain.

             17.2 "SUBSIDIARY" means any corporation (other than the Company) in
an unbroken chain of corporations beginning with the Company if each of the
corporations other than the last corporation in the unbroken chain owns stock
possessing 50% or more of the total combined voting power of all classes of
stock in one of the other corporations in such chain.

             17.3 "AFFILIATE" means any corporation that directly, or indirectly
through one or more intermediaries, controls or is controlled by, or is under
common control with, another corporation, where "control" (including the terms
"controlled by" and "under common control with") means the possession, direct or
indirect, of the power to cause the direction of the management and policies of
the corporation, whether through the ownership of voting securities, by contract
or otherwise.

             17.4 "FAIR MARKET VALUE" means, as of any date, the value of a
share of the Company's Common Stock determined as follows:

             (a)     if such Common Stock is then quoted on the Nasdaq National
                     Market, its closing price on the Nasdaq National Market on
                     the date of determination as reported in The Wall Street
                     Journal;

             (b)     if such Common Stock is publicly traded and is then listed
                     on a national securities exchange, its closing price on the
                     date of determination on the principal national securities
                     exchange on which the Common Stock is listed or admitted to
                     trading as reported in The Wall Street Journal;

             (c)     if such Common Stock is publicly traded but is not quoted
                     on the Nasdaq National Market nor listed or admitted to
                     trading on a national securities exchange, the average of
                     the closing bid and asked prices on the date of
                     determination as reported in The Wall Street Journal;

             (d)     in the case of an Option granted on the Effective Date,
                     the price per share at which shares of the Company's
                     Common Stock are initially offered for sale to the
                     public by the Company's underwriters in the initial
                     public

<PAGE>   5

                     offering of the Company's Common Stock pursuant to a
                     registration statement filed with the SEC under the
                     Securities Act; or

             (e)     if none of the foregoing is applicable, by the Committee
                     in good faith.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00025-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00025-of-00352.parquet"}]]